Ceremony 发表于 2025-3-25 04:43:13

Submitted on: 10 March 2000.
Revised on: 07 July 2000.
Accepted on: 23 August 2000.

___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

faction 发表于 2025-3-25 10:07:41

Submitted on: 28 February 2020.
Revised on: 23 March 2020.
Accepted on: 12 May 2020.

___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

Cleave 发表于 2025-3-25 13:21:26

Submitted on: 22 January 2024.
Revised on: 19 February 2024.
Accepted on: 09 April 2024.

___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

BRACE 发表于 2025-3-25 16:27:06

http://reply.papertrans.cn/2/116/11573/11573-24.png

座右铭 发表于 2025-3-25 19:59:06

http://reply.papertrans.cn/2/116/11573/11573-25.png

Spinous-Process 发表于 2025-3-26 04:12:30

http://reply.papertrans.cn/2/116/11573/11573-26.png

GLOOM 发表于 2025-3-26 08:16:16

http://reply.papertrans.cn/2/116/11573/11573-27.png

妨碍议事 发表于 2025-3-26 09:24:47

Submitted on: 11 September 2001.
Revised on: 20 November 2001.
Accepted on: 06 January 2002.

___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

诱导 发表于 2025-3-26 13:17:49

Submitted on: 29 August 2013.
Revised on: 30 October 2013.
Accepted on: 13 December 2013.

___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

大洪水 发表于 2025-3-26 17:44:32

Submitted on: 28 April 2024.
Revised on: 08 July 2024.
Accepted on: 16 August 2024.

___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC
页: 1 2 [3] 4
查看完整版本: SCIE期刊HUMAN GENE THERAPY 2024/2025影响因子:3.988 (HUM GENE THER) (1043-0342). (MEDICINE, RESEARCH & EXPERIMENTAL)(医学、研究和实验)